Angela Carville
Overview
Explore the profile of Angela Carville including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
3296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Braun S, Taube R, Zhu Q, Wong F, Murakami A, Kamau E, et al.
Hum Gene Ther
. 2012 Jun;
23(9):917-31.
PMID: 22734618
We evaluated the potential of an anti-human immunodeficiency virus (HIV) Tat intrabody (intracellular antibody) to promote the survival of CD4(+) cells after chimeric simian immunodeficiency virus (SIV)/HIV (SHIV) infection in...
12.
Mire C, Miller A, Carville A, Westmoreland S, Geisbert J, Mansfield K, et al.
PLoS Negl Trop Dis
. 2012 Mar;
6(3):e1567.
PMID: 22448291
The filoviruses, Marburg virus and Ebola virus, cause severe hemorrhagic fever with high mortality in humans and nonhuman primates. Among the most promising filovirus vaccines under development is a system...
13.
Barouch D, Liu J, Li H, Maxfield L, Abbink P, Lynch D, et al.
Nature
. 2012 Jan;
482(7383):89-93.
PMID: 22217938
Preclinical studies of human immunodeficiency virus type 1 (HIV-1) vaccine candidates have typically shown post-infection virological control, but protection against acquisition of infection has previously only been reported against neutralization-sensitive...
14.
Li H, Liu J, Carville A, Mansfield K, Lynch D, Barouch D
J Virol
. 2011 Sep;
85(21):11007-15.
PMID: 21917969
The induction of potent and durable cellular immune responses in both peripheral and mucosal tissues may be important for the development of effective vaccines against human immunodeficiency virus type 1...
15.
Reeves R, Rajakumar P, Evans T, Connole M, Gillis J, Wong F, et al.
Blood
. 2011 Jul;
118(12):3321-30.
PMID: 21791421
Natural killer (NK) cells are classically viewed as effector cells that kill virus-infected and neoplastic cells, but recent studies have identified a rare mucosal NK- cell subpopulation secreting the TH17...
16.
Orlova N, Fogg M, Carville A, Wang F
Clin Vaccine Immunol
. 2011 Jul;
18(9):1427-34.
PMID: 21734064
Humoral immune responses to rhesus lymphocryptovirus (rhLCV) lytic infection proteins were evaluated in the rhesus macaque animal model for Epstein-Barr virus (EBV) infection. We found a hierarchy of humoral responses...
17.
Wilks A, Perry J, Ehlinger E, Zahn R, White R, Gauduin M, et al.
J Virol
. 2011 Jul;
85(18):9517-26.
PMID: 21734053
The design of immunologic interventions to prevent postnatal transmission of human immunodeficiency virus (HIV) will require identification of protective immune responses in this setting. Simian immunodeficiency virus (SIV)-infected rhesus monkeys...
18.
Barouch D, Kik S, Weverling G, Dilan R, King S, Maxfield L, et al.
Vaccine
. 2011 May;
29(32):5203-9.
PMID: 21619905
Recombinant adenovirus serotype 5 (rAd5) vaccine vectors for HIV-1 and other pathogens have been shown to be limited by high titers of Ad5 neutralizing antibodies (NAbs) in the developing world....
19.
Sampson S, Mansfield K, Carville A, Magee D, Quitugua T, Howerth E, et al.
Vaccine
. 2011 May;
29(29-30):4839-47.
PMID: 21549795
We have previously described the development of a live, fully attenuated Mycobacterium tuberculosis (Mtb) vaccine candidate strain with two independent attenuating auxotrophic mutations in leucine and pantothenate biosynthesis. In the...
20.
Manrique M, Kozlowski P, Cobo-Molinos A, Wang S, Wilson R, Montefiori D, et al.
J Immunol
. 2011 Feb;
186(6):3581-93.
PMID: 21317390
The efficacy of two SIV DNA plus recombinant modified vaccinia virus Ankara nasal vaccine regimens, one combined with plasmids expressing IL-2 and IL-15, the other with plasmids expressing GM-CSF, IL-12,...